October 09, 2017 1:08 PM
SHANGHAI (REUTERS, BLOOMBERG) – China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market.
# @News